Trustees of The University of Pennsylvania Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genpact
G
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$15.1M |
| 2 |
ADXS
Advaxis Inc
ADXS
|
+$96K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.17% |
| 2 | Healthcare | 0% |
Similar funds
Trustees of The University of Pennsylvania's Q4 2014 Portfolio in Review
As of Q4 2014, Trustees of The University of Pennsylvania held 3 positions worth $33M, down 13% from $38.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trustees of The University of Pennsylvania withdrew a net $4.35M in Q4 2014, closing 1 position and reducing 1 holding. Its most notable exit was Advaxis Inc, an estimated $96K position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 0% a quarter earlier, followed by Healthcare.
Against the trend, Trustees of The University of Pennsylvania opened a new position in Genpact worth $11.6M.
- Trustees of The University of Pennsylvania's largest Q4 2014 buy was Genpact: 612,942 shares worth $11.6M.
- Trustees of The University of Pennsylvania's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $15.1M.
- Trustees of The University of Pennsylvania fully exited Advaxis Inc in Q4 2014, selling an estimated $96K.
- Trustees of The University of Pennsylvania's ten largest holdings make up 100% of its $33M portfolio in Q4 2014.
- Trustees of The University of Pennsylvania opened 1 new position and closed 1 in Q4 2014.
- Trustees of The University of Pennsylvania's portfolio value fell 13% quarter-over-quarter to $33M.
Based on Trustees of The University of Pennsylvania's 13F filing for Q4 2014, filed 11 Feb 2015.